Metabolic Health
Explore medicines and research compounds linked with appetite, blood sugar, weight and metabolic health. Some are well established, while others are still being tested.
Explore the area, then follow the evidence. These compounds appear here because they are studied or commonly discussed in this category. Open a profile to see what the research actually supports.
Explore metabolic health
The compounds with complete profiles, brought together around the reasons people are interested in this area.
Semaglutide
GLP-1 receptor agonist with extensive diabetes and weight-management research.
Tirzepatide
Dual incretin agonist studied across diabetes, obesity and related outcomes.
Retatrutide
Triple-receptor agonist in late-stage metabolic research.
Cagrilintide
Amylin analogue investigated in weight and metabolic programmes.
MOTS-c
Mitochondrial-derived peptide investigated in metabolic and exercise biology.
Tesamorelin
GHRH analogue studied in a defined indication involving visceral adipose tissue.